Graduated in Pharmacy from the Universitat de Barcelona in 2018 and holding a Master’s degree in Global Health from the Vrije Universiteit Amsterdam (2021), she has training in public health and epidemiology. After completing her master’s degree, she worked at the Epidemiological Surveillance Unit of the Department of Health of the Generalitat de Catalunya, participating in outbreak investigations and the control of communicable diseases.

She is currently a predoctoral (PhD) student at the Universitat de Girona, within the Doctoral Program in Molecular Biology, Biomedicine, and Health (since 2025). Her line of research focuses on pharmacoepidemiology and evaluating the effectiveness of PCSK9 inhibitors using real-world data and their impact on cardiovascular events. She carries out her research activities at the Institut d’Investigació en Atenció Primària Jordi Gol (IDIAP Jordi Gol), where she participates in the design and implementation of research projects in primary care, with a special interest in cardiovascular prevention and shared decision-making in patients with vascular disease, as well as in the coordination of the RICAPPS network (Research Network on Chronicity, Primary Care, Prevention and Health Promotion).